Evidence map›Paper›PMID 40496983›Full record

ArticleOpen forum infectious diseases2025

Association of SARS-CoV-2 With Health-related Quality of Life 1 Year After Illness Using Latent Transition Analysis.

Lauren E Wisk, Michael Gottlieb, Peizheng Chen, Huihui Yu, Kelli N O'Laughlin, Kari A Stephens, Graham Nichol, Juan Carlos C Montoy, Robert M Rodriguez, Michelle Santangelo and 12 more

Registry-linked trialAbstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04610515 (Innovative Support for Patients With SARS-COV2 Infections), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04610515 completednot on this map

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

Typeobservational_patient_registrySponsorRush University Medical CenterRan2020 to 2025Enrolled6,000ConditionsCovid19, ME/CFS, SARS COV2, Novel Coronavirus Infection
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. The impact of testing positive versus negative for COVID-19 on health-related quality of life: cross-sectional evidence from the Alberta post-COVID-19 follow-up survey.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  2. Article
  3. Article
  4. Cognitive Function 1 Year After COVID Infection.Open forum infectious diseases · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Lauren E WiskDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.ORCID https://orcid.org/0000-0003-2932-4140
Michael GottliebDepartment of Emergency Medicine, Rush University Medical Center, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0003-3276-8375
Peizheng ChenSection of Cardiovascular Medicine, Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0009-0001-9903-8062
Huihui YuSection of Cardiovascular Medicine, Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0003-4019-3831
Kelli N O'LaughlinDepartment of Emergency Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-3027-1883
Kari A StephensDepartment of Family Medicine, University of Washington, Seattle, Washington, USA.
Graham NicholHarborview Center for Prehospital Emergency Care, University of Washington, Seattle, Washington, USA.
Juan Carlos C MontoyDepartment of Emergency Medicine, University of California, San Francisco, San Francisco, California, USA.ORCID https://orcid.org/0000-0001-7438-0243
Robert M RodriguezDepartment of Medicine, University of California Riverside School of Medicine, Riverside, California, USA.
Michelle SantangeloDepartment of Emergency Medicine, Rush University Medical Center, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0003-4353-0995
Kristyn GatlingDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois, USA.ORCID https://orcid.org/0009-0004-2294-1650
Erica S SpatzSection of Cardiovascular Medicine, Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0002-1557-7713
Arjun K VenkateshSection of Cardiovascular Medicine, Center for Outcomes Research and Evaluation (CORE), Yale School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0002-8248-0567
Kristin L RisingDepartment of Emergency Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-3882-4956
Mandy J HillDepartment of Emergency Medicine, McGovern Medical School, UT Health Houston, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-9778-358X
Ryan HuebingerDepartment of Emergency Medicine, McGovern Medical School, UT Health Houston, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-9448-5744
Ahamed H IdrisDepartment of Emergency Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.ORCID https://orcid.org/0000-0001-7113-6499
Michael WillisDepartment of Neurology, University of Washington, Seattle, Washington, USA.
Efrat KeanDepartment of Emergency Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Samuel A McDonaldDepartment of Emergency Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
Joann G ElmoreDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Robert A WeinsteinDepartment of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-3390-858X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Long-term sequelae after SARS-CoV-2 infection may impact health-related quality-of-life (HRQoL), yet it is unknown how HRQoL changes during recovery. We compared patient-reported HRQoL among adults with COVID-19-like illness who tested SARS-CoV-2 positive (COVID+) with those who tested negative (COVID-). Methods: Participants in this prospective, multicenter, longitudinal registry study were enrolled from December 2020 through August 2022 and completed 3-month follow-up assessments until 12 months after enrollment. Participants were adults (≥18 years) with acute symptoms suggestive of COVID-19 who received a Food and Drug Administration-approved SARS-CoV-2 test. Participants received questions from PROMIS-29 (subscales: physical function, anxiety, depression, fatigue, social participation, sleep disturbance, and pain interference) and PROMIS SF-8a (cognitive function). Latent transition analysis was used to identify meaningful patterns in HRQoL scores over time; 4 HRQoL categories were compared descriptively and using multivariable regression. Inverse probability weighting was used to adjust for covariate imbalance. Results: There were 1096 (75%) COVID+ and 371 (25%) COVID-. Four distinct well-being classes emerged: optimal overall, poor mental, poor physical, and poor overall HRQoL. COVID+ participants were more likely to return to the optimal HRQoL class compared to COVID- participants. The most substantial transition from poor physical to optimal HRQoL occurred by 3 months, whereas movement from poor mental to optimal HRQoL occurred by 9 months. Conclusions: In adults with COVID-19-like illness, COVID+ participants demonstrated meaningful recovery in their physical HRQoL by 3 months after infection, but mental HRQoL took longer to improve. Suboptimal HRQoL at 3 to 12 months after infection remained in approximately 20%. Trial Registration: NCT04610515.

Indexed as

COVID-19health-related quality of lifeprospective cohort studySARS-CoV-2

Identifiers

PMID40496983
PMCPMC12150399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.